| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
59,892,000 | 52,853,000 | 53,101,000 | 54,228,000 | 63,054,000 |
|
Cost of Revenue
|
-35,997,000 | -34,478,000 | -35,756,000 | -32,517,000 | -36,188,000 |
|
Gross Profit
|
23,895,000 | 18,375,000 | 17,345,000 | 21,711,000 | 26,866,000 |
|
Selling, General and Administrative Expenses
|
-4,417,000 | -4,624,000 | -5,507,000 | -5,634,000 | -7,002,000 |
|
Research and Development Expenses
|
-13,452,000 | -13,774,000 | -16,546,000 | -16,046,000 | -17,528,000 |
|
Operating Income/Expenses
|
-17,869,000 | -18,398,000 | -22,053,000 | -21,680,000 | -24,530,000 |
|
Total Operating Profit/Loss
|
6,026,000 | -23,000 | -4,708,000 | 31,000 | 2,336,000 |
| Total Net Finance Income/Expense
|
616,000 | -271,000 | 981,000 | 629,000 | 166,000 |
| Net Investment Income
|
-12,324,000 | -982,000 | -166,000 | 254,000 | 4,458,000 |
| Irregular Income/Expenses
|
-4,763,000 | 2,833,000 | -7,317,000 | -152,000 | 808,000 |
|
Non-Operating Income/Expenses, Total
|
-16,471,000 | 1,580,000 | -6,502,000 | 731,000 | 5,432,000 |
|
Pretax Income
|
-10,445,000 | 1,557,000 | -11,210,000 | 762,000 | 7,768,000 |
|
Provision for Income Tax
|
-1,497,000 | -1,531,000 | -8,023,000 | 913,000 | 249,000 |
|
Net Income from Continuing Operations
|
-11,942,000 | 26,000 | -19,233,000 | 1,675,000 | 8,017,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-11,942,000 | 26,000 | -19,233,000 | 1,675,000 | 8,017,000 |
|
Non-Controlling/Minority Interests
|
-90,000 | -293,000 | 477,000 | 14,000 | -3,000 |
|
Net Income after Non-Controlling/Minority Interests
|
-12,032,000 | -267,000 | -18,756,000 | 1,689,000 | 8,014,000 |
|
Net Income Available to Common Stockholders
|
-12,032,000 | -267,000 | -18,756,000 | 1,689,000 | 8,014,000 |
|
Diluted Net Income Available to Common Stockholders
|
-12,032,000 | -267,000 | -18,756,000 | 1,689,000 | 8,014,000 |
|
Common Dividend per Share
|
0.00 | -- | 0.38 | 0.74 | 1.46 |
| Basic EPS
|
-2.34 | -0.06 | -4.38 | 0.40 | 1.95 |
| Diluted EPS
|
-2.34 | -0.06 | -4.38 | 0.40 | 1.94 |
|
Basic Weighted Average Shares Outstanding
|
5,070,000 | 4,530,000 | 4,280,000 | 4,190,000 | 4,108,000 |
|
Diluted Weighted Average Shares Outstanding
|
5,070,000 | 4,530,000 | 4,280,000 | 4,212,000 | 4,123,000 |
|
Reported Normalized Diluted EPS
|
0.57 | 0.42 | -0.13 | 1.05 | 1.84 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-10,707,000 | 1,641,000 | -11,981,000 | 305,000 | 7,675,000 |
|
EBITDA
|
1,912,000 | 13,347,000 | -602,000 | 9,907,000 | 20,710,000 |
|
Normalized EBITDA
|
34,344,000 | 16,241,000 | 12,543,000 | 13,067,000 | 18,814,000 |
|
Normalized Income
|
12,197,137.60 | 1,929,000 | -566,000 | 4,423,000 | 6,891,000 |
12/31/2022 - 10/27/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade